Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | €130.75 | €140.87 | 7.738% |
| AbbVie Inc. | 42 | 0 | 20 | 0 | €154.16 | €176.14 | 14.258% |
| Sarepta Therapeutics | 9 | 0 | 8 | 0 | €139.40 | €180.00 | 29.125% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €177.60 | €182.79 | 2.922% |
| Zoetis Inc. A | 24 | 1 | 1 | 0 | €162.74 | €198.11 | 21.735% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €237.60 | €256.11 | 7.789% |
| United Therapeutics | 22 | 0 | 3 | 0 | €292.60 | €289.92 | -0.916% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.80 | €291.35 | 38.209% |
| Amgen Inc. | 34 | 0 | 11 | 0 | €289.95 | €305.58 | 5.389% |
| Madrigal Pharmaceuticals inc. | 4 | 0 | 1 | 0 | €266.00 | €320.00 | 20.301% |
| Medpace Holdings Inc | 13 | 0 | 2 | 0 | €376.10 | €420.00 | 11.672% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 11 | 0 | €448.00 | €459.80 | 2.634% |
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €854.90 | €900.00 | 5.275% |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €967.40 | €1,049.8 | 8.514% |